AI assistant
Sending…
Navamedic — Director's Dealing 2019
Dec 23, 2019
3668_dirs_2019-12-23_0d8238e3-4511-40e9-819a-79b8a38da8e7.html
Director's Dealing
Open in viewerOpens in your device viewer
Disclosure of trade
Disclosure of trade
With reference to disclosure requirements set out in section 4-2 of the Norwegian Securities Trading Act, Lars Hjarrand, a primary insider as Chief Financial Officer in Navamedic ASA, has on December 20th, 2019 acquired 132.882 shares in Navamedic ASA at an average price of 16,5564 NOK. After this transaction Lars Hjarrand owns 132.882 shares in the company.
More from Navamedic
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 20
Major Shareholding Notification
2026
May 20
Major Shareholding Notification
2026
May 19
Director's Dealing
2026
May 18
Director's Dealing
2026
May 18
Major Shareholding Notification
2026
May 15
Major Shareholding Notification
2026
May 15
Investor Presentation
2026
Apr 23
Investor Presentation
2026
Apr 23